Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (191-200 of 358) with videos related to

Pageof 36
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2007
Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug usersFrancesco G De Rosa, Olivia Bargiacchi, Sabrina Audagnotto, et al.
British Journal of Clinical Pharmacology|August 15, 2017
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in childrenSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
Journal of Medical Virology|July 8, 2020
The "scar" of a pandemic: Cumulative incidence of COVID-19 during the first trimester of pregnancyStefano Cosma, Fulvio Borella, Andrea Carosso, et al.
Hepatology (Baltimore, Md.)|January 21, 2014
Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirinTeresa Santantonio, Massimo Fasano, Evangelista Sagnelli, et al.
The Journal of Infection|March 22, 2006
Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patientFrancesco G De Rosa, Sabrina Audagnotto, Olivia Bargiacchi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 27, 2013
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spotsLorena Baietto, Antonio D'Avolio, Alessandra Ariaudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2008
Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavirMarco Siccardi, Antonio D'Avolio, Lorena Baietto, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2018
Laboratory findings in Zika infection: The experience of a reference centre in North-West ItalyElisa Burdino, Maria Grazia Milia, Tiziano Allice, et al.
AIDS (London, England)|November 8, 2023
Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIVMattia Trunfio, Alessandra Sacchi, Daniela Vai, et al.
British Journal of Clinical Pharmacology|July 5, 2018
Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherenceValeria Avataneo, Amedeo De Nicolò, Franco Rabbia, et al.
Pageof 36

Showing results (191-200 of 358) with videos related to

Sort By:
Pageof 36
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2007
Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug usersFrancesco G De Rosa, Olivia Bargiacchi, Sabrina Audagnotto, et al.
British Journal of Clinical Pharmacology|August 15, 2017
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in childrenSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
Journal of Medical Virology|July 8, 2020
The "scar" of a pandemic: Cumulative incidence of COVID-19 during the first trimester of pregnancyStefano Cosma, Fulvio Borella, Andrea Carosso, et al.
Hepatology (Baltimore, Md.)|January 21, 2014
Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirinTeresa Santantonio, Massimo Fasano, Evangelista Sagnelli, et al.
The Journal of Infection|March 22, 2006
Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patientFrancesco G De Rosa, Sabrina Audagnotto, Olivia Bargiacchi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 27, 2013
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spotsLorena Baietto, Antonio D'Avolio, Alessandra Ariaudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2008
Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavirMarco Siccardi, Antonio D'Avolio, Lorena Baietto, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2018
Laboratory findings in Zika infection: The experience of a reference centre in North-West ItalyElisa Burdino, Maria Grazia Milia, Tiziano Allice, et al.
AIDS (London, England)|November 8, 2023
Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIVMattia Trunfio, Alessandra Sacchi, Daniela Vai, et al.
British Journal of Clinical Pharmacology|July 5, 2018
Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherenceValeria Avataneo, Amedeo De Nicolò, Franco Rabbia, et al.
Pageof 36